BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Hepatol. Jun 27, 2026; 18(6): 120258
Published online Jun 27, 2026. doi: 10.4254/wjh.120258
Table 4 Representative SHapley Additive exPlanation case examples, median (interquartile rage)/n (%)
Variable
Group characteristics
Value (SHAP value)
Fibrosis < 2 (n = 168)
Fibrosis ≥ 2 (n = 29)
Case 1
Case 2
Case 3
Case 4
LSM (kPa)6.0 (4.6-8.0)12.1 (8.0-20.9)3.9 (-2.78)4.9 (-3.29)7.7 (-0.47)5 (-3.34)
Graft age (year)1.0 (0.3-2.3)3.4 (2.6-8.9)0.7 (-1.55)4.0 (+0.62)14.8 (+2.39)4.7 (+0.77)
Age (year)58.8 (49.7-63.0)49.0 (38.8-56.1)62.5 (-1.17)59.0 (-1.43)42.0 (+1.70)59.0 (-1.4)
BMI26.9 (25.8-31.1)26.5 (24.5-27.6)26.9 (+0.27)21.3 (+0.80)26.9 (+0.64)24.5 (+0.92)
HGB127.0 (113.5-136.0)134.0 (122.0-145.0)131 (+0.13)144 (+0.34)158 (+0.57)124 (-0.11)
ALP112.0 (85.7-163.0)134.0 (108.0-229.0)77 (-0.11)125 (+0.35)52 (-0.11)175 (-0.21)
Living donor62 (36.9)6 (20.7)No (+0.07)No (+0.21)No (+0.22)No (+0.21)
AST27.0 (19.7-41.2)41.0 (28.0-58.0)10 (-0.21)29 (-0.12)22 (-0.10)38 (+0.14)
HTN pre-transplant (yes/no)37 (22.0)2 (6.9)No (-0.04)No (-0.01)No (-0.01)No (-0.01)


Write to the Help Desk